A number of labs in the pharma/biotech industry and in academia are now focusing their efforts on new ways to modulate the immune system to target cancer. Advances, both in understanding immune pathways and in developing tools to target and exploit these pathways, have led to remarkable progress in this relatively new field. The Scientist brings together a panel of experts who will delve into the hope and hype in an effort to educate the audience about the new findings in cancer immunotherapy. Attendees can interact with the experts during the live webinar by asking questions and sharing their experiences on this topic.

Topics to be covered:

  • Basic concepts underlying immunomodulation for oncology
  • New drug entities: immunomodulatory agents, vaccines, monoclonal antibodies, and more
  • Challenges in drug development
  • New tools for screening and validation
  • Use of biomarkers for targeted therapies

Meet the Speakers:

Dr. Jedd Wolchok
Chief, Melanoma & Immunotherapeutics Service...



Dr. Tibor Keler
Senior Vice President and Chief Scientific Officer
Celldex Therapeutics


Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?